If one only takes CEA measurements when a patient has abdominal pain following treatment for colorectal cancer, one will overestimate the association of elevated CEA with colorectal cancer recurrence (see chapter on ‘Some Statistical Methods for Immunodiagnostic Cancer Tests’ in Herberman and Mercer).51 Here, CEACAM5 is linked to colorectal cancer.